The combined overexpression of programmed death-ligand 1 (PD-L1) and Akt in adipose-derived mesenchymal stem cells (AdMSCs) has emerged as a promising strategy for myocardial infarction (MI) therapy. The gene discussed is CD274; the disease is myocardial infarction.